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Because hair follicles originate within 
an organ whose primary role is bar-
rier to water loss, one would assume 
that hair follicle structure and function 
must also be dominated by lipid com-
ponents: lipids to repel water, lipids 
to maintain the permeability barrier, 
lipids to maintain structure, and lipid 
messengers. Yet, when serious atten-
tion is given to this deceptively simple 
appendage, the focus is usually on its 
protein structure and peptide signal-
ing. Where lipids have been implicated 
in hair follicle pathology, the findings 
have been made serendipitously (e.g., 
Sundberg et al., 2000; Moulson et al., 
2003; Westerberg et al., 2004; Lee et 
al., 2007; Shimomura et al., 2009), 
without a deep understanding of the 
finding within the big picture. For 
those of us who live with the follicle, 
it is satisfying to note that in the past 
3 years as many papers have appeared 
describing fundamental lipid pathways, 
which, when perturbed, cause severe 
hair follicle injury.
In 2007 Wan et al. described a 
mammary gland–specific peroxi-
some proliferator–activated receptor-γ 
(PPARγ) knockout mouse that showed 
no phenotype itself. But pups suckling 
on the mutant dam developed an alo-
pecia induced by oxidized lipids car-
ried in the milk. Once weaned and 
freed of the toxin-containing milk, the 
pups regained their hair. The affected 
skin exhibited abnormal follicle growth 
and cycling, dilated pilary canals, 
follicle arrest in an abnormal catagen/
telogen, and a dermis housing inflam-
matory cells. The contribution made 
by Karnik et al. (2009) related to the 
association of PPARγ deficiency with 
a form of human cicatricial alopecia. 
By gene array analysis and real-time 
PCR, this group demonstrated the 
downregulation of PPARγ and PPARγ-
regulated genes required for choles-
terol biosynthesis, lipid metabolism, 
and peroxisome biogenesis in patients 
with lichen planopilaris (LPP). When 
these investigators knocked out PPARγ 
expression in the stem cells of mouse 
hair follicles, not only did the mutation 
recapitulate many of the gene expres-
sion and histological findings of LPP, 
it also induced follicle cyst formation, 
dystrophic catagen/telogen forms, and 
dermal inflammation.
The current issue of the Journal of 
Investigative Dermatology features 
work from a group with long-term 
interest in cholesterol metabolism. 
Cholesterol has been suspected of play-
ing a role in normal hair biology, as 
illustrated by the hair loss suffered by 
some patients taking cholesterol-reduc-
ing statins. In the current study, Evers et 
al. (2010) asked the inverse question. 
They studied the effect of an upregu-
lated cholesterol synthesis pathway in 
mouse hair follicles by knocking out 
the expression of Insig proteins, inhibi-
tors of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase, the rate-limiting 
enzyme of cholesterol biosynthesis. 
Insig proteins normally control choles-
terol synthesis by decreasing it whenev-
er sterol levels are high. In this model, 
sterol precursors accumulated in the 
hair follicle epithelium, causing distor-
tion of whiskers and hair shafts; ectatic, 
keratin-plugged distal follicles; and 
abnormally arrested catagen/telogen 
forms.
The approaches taken in the three 
studies have fundamental differences, 
such as in the expression site of the 
hair follicle mutation: the mammary 
gland, hair follicle stem cell lineage, 
and epidermis and hair follicle sheath. 
The cells expressing the mutation also 
differ: endothelial/hematopoietic cells 
(Wan et al., 2007), hair follicle epithe-
lial stem cells (Karnik et al., 2009), and 
oral epithelium/epidermis/hair follicle 
outer root sheath (Evers et al., 2010). 
Nonetheless, many of the changes 
observed are remarkably similar. For 
example, hair shaft distortion, distal 
follicle ectasia (pseudocyst), keratin 
plugging of the pilary canal, dystrophic 
catagen/telogen forms, and dermal 
inflammation are found to a variable 
degree in all three studies. In addition, 
the phenotype in the first two studies 
is dramatically reversible, so, despite 
significant follicle distortion, under the 
proper rescue therapy normal follicles 
reform, a feature no doubt reflecting the 
regenerative power of the follicle itself.
Equating the phenotypic similarities 
of the three mutants with the data at 
hand may perhaps be a stretch in logi-
cal thought, although the downstream 
factors accumulating in the absence 
of PPARγ are common, including the 
upregulated prostaglandin and lipoxy-
genase pathways and downregulated 
lipid metabolic pathways. None of the 
studies defines a mechanism to explain 
how the cellular follicular changes 
occur: why do the distal follicles dilate, 
why does the follicle lumen fill with 
keratin, why do the hairs crimp? What 
causes dermal inflammation? What is 
the link between altered lipid metab-
olism, inflammation, and disrupted 
hair follicles? The three studies clearly 
show an apparent toxic effect on hair 
follicle cycling—the pathology is clear. 
The role of these lipid metabolic path-
ways in normal hair follicle biology and 
the mechanism by which changes in 
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these pathways cause the pathological 
phenotype remain unclear, and such 
questions need attention.
A trivial explanation for the com-
mon features of the variants in these 
reports might be that upon insult the 
hair follicle can muster only one, or 
a few, cell responses to injury. One 
such response would be the inflam-
mation induced by proinflamma-
tory lipids or sterols. We now know 
that there is an extensive, delicately 
balanced interaction between the 
immune and metabolic pathways, 
an interaction that is dysfunctional in 
chronic metabolic diseases such as 
type 2 diabetes and atherosclerosis 
(Hotamisligil, 2006; Wellen et al., 
2007). Although there are short-term 
compensatory and adaptive measures 
that keep this delicate balance in 
check, the outcome could be detri-
mental if one arm overwhelmed the 
other in the long run. For example, 
Karnik et al. (2009) have reported that 
LPP includes a chronic disturbance of 
metabolic homeostasis in hair follicle 
cells due to inactivation of PPARγ. 
The PPAR and liver X receptor fami-
lies of transcription factors seem to be 
crucial for modulating the intersec-
tion of metabolic and inflammatory 
pathways (Bensinger and Tontonoz, 
2008). Activation of these transcription 
factors inhibits the expression of sever-
al genes involved in the inflammatory 
response, with the implication that loss 
of activation of these factors will not 
only disturb metabolic homeostasis 
but also induce inflammatory damage 
to tissues, such as the hair follicle.
A second cellular response to dis-
turbed lipid homeostasis could be 
organelle stress. The endoplasmic 
reticulum (ER), mitochondria, and per-
oxisomes are important sites for the 
metabolism of lipids, especially phos-
pholipids and cholesterol, and for the 
monitoring of their intracellular status 
(Murphy et al., 2009). For example, 
cholesterol sensing is initiated at the 
ER membrane through the transcrip-
tion factor sterol-regulatory-element-
binding protein (Colgan et al., 2007). 
Organelle stress induced by chronic 
disturbance of metabolic homeostasis 
in hair follicle cells could lead to the 
generation of reactive oxygen species 
by the ER and mitochondria, leading 
to activation of stress and inflammatory 
signaling cascades and oxidative dam-
age (Ron and Walter, 2007; Todd et al., 
2008). If ER and mitochondrial homeo-
stasis were not restored, the organelles 
could activate apoptotic pathways in 
the hair follicle, destroying it.
A third mechanism linking lipid 
homeostasis to the hair follicle is lipid 
modification of signaling proteins such 
as Hedgehogs (Hhs) and Wnts, which 
are necessary for hair follicle morpho-
genesis and cycling. The N-terminus of 
Hh becomes modified by the fatty acid 
palmitate on a conserved cysteine resi-
due, whereas the C terminus is cho-
lesterol modified. Wnt molecules are 
palmitoylated on the first conserved 
cysteine (C77), a residue that is pres-
ent on all Wnts. Genetic data suggest 
that lipid modification localizes the 
Wnt and Hh proteins to membranes, 
a requirement for Wnt and Hh protein 
activity (Nusse, 2003). A site-directed 
mutation in one of the endogenous 
Hh genes in the mouse (sonic hedge-
hog) demonstrated that loss of choles-
terol modification attenuates the range 
of Hh activity, and perhaps even a 
loss, of Hh activity (Lewis et al., 2001). 
Alterations in fatty acid metabolism or 
cholesterol biosynthesis as a result of 
PPARγ loss (Wan et al., 2007; Karnik 
et al., 2009) or sterol precursor accu-
mulation (Evers et al., 2010, this issue) 
could prevent appropriate lipid modi-
fication of Wnt and Hh and thereby 
interfere with hair follicle morpho-
genesis and cycling.
Evers et al. postulate that disruption 
of the Sonic Hh pathway might have 
been caused by the high concentrations 
of tissue sterols observed, although the 
possibility that other morphogenetic 
pathways, such as Wnt (Bazan and 
deSauvage, 2009) and Notch (Demehri 
and Kopan, 2009), are also affected by 
tissue sterols could not be ruled out. 
We have observed similar histologi-
cal changes in mutants ranging from a 
stearoyl coenzyme A desaturase gene 
mutant in the asebia mouse (Sundberg 
et al., 2000) to the follicle changes in a 
mouse with Sox 9 gene knockout (VPJ 
Vidal, personal communication, 2006). 
Nevertheless, any or all of the mecha-
nisms discussed may plausibly connect 
the toxic insult and the cellular chang-
es observed.
A parallel for some of the 
pathological changes described in 
these models can be found in several 
forms of clinical cicatricial alopecia as 
well as in acne vulgaris. On the basis 
of the observations reported by Evers et 
al., we would predict that lipids play a 
significant role in hair follicle morpho-
genesis and cycling and that alterations 
in lipid pathways underlie many clini-
cal hair follicle disorders.
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Clinicians routinely interpret clinical 
measurements such as blood pressure 
or hematocrit: almost without think-
ing, we “know” what the values mean 
for a patient’s health. This knowledge 
is based on our experience caring for 
many patients and on what we have 
learned from teachers and reading.
For many measurements in clinical 
studies we lack this intuition, however. 
One of the original studies of finasteride 
for benign prostatic hyperplasia graphi-
cally illustrates this point (Lydick and 
Epstein, 1993; Gormley et al., 1992). 
Compared with placebo, the drug 
improved urine flow by an average of 
3 ml/second—a rather bland finding, 
to be sure—until a subsequently pub-
lished epidemiological study found that 
for men aged 40–74 typical urine flow 
rates decline approximately 0.2–0.3 ml/
second per year of life (Girman et al., 
1993). We can now interpret the real-
world effect of finasteride: on average, 
it restores a man’s urinary flow to what 
it was 10–15 years earlier.
Interpreting measurements such 
as urine flow is relatively straight-
forward compared with interpreting 
more abstract health outcomes such 
as scores of patients’ reports concern-
ing their experience with illness. The 
actual measurement of psychometric 
constructs is a highly advanced and rig-
orous science, and substantial progress 
has been made in applying this science 
to clinical medicine (Both et al., 2007). 
Dermatology has lagged somewhat in 
rigorous studies to interpret the mean-
ing of psychometric scores, however, 
and these scores remain unfamiliar to 
most researchers and clinicians. It is 
highly fitting that in what the Journal 
has designated the Year of the Patient 
(Bergstresser, 2010), this issue contains 
a good example of a study to facilitate 
interpretation of one measurement of 
patients’ experience of illness (Prinsen 
et al., 2010). In this Commentary, I 
describe briefly where we are with 
respect to measuring patients’ reports, 
summarize the major findings of that 
article, and project where we might go 
next to advance this important aspect of 
clinical research.
Patients’ reports of their experience 
with illness are a key health outcome. 
This observation is especially true for 
skin diseases, which do not typically 
affect survival, laboratory values, or eas-
ily measured clinical changes. In fact, 
patients’ reports are arguably an essential 
health outcome for dermatology because 
skin diseases (unlike most “internal” dis-
eases) can change appearance, and they 
may have psychological and functional 
effects that cannot be assessed except 
through patients’ reports.
Most scientific work on the assess-
ment of patients’ experience with cuta-
neous illness has focused on instruments 
that measure skin-related quality of life. 
Generic and disease-specific quality-of-
life instruments have been developed 
